Your browser doesn't support javascript.
loading
Intestinal Microbiota in Children With Symptomatic Dientamoeba fragilis Infection: A Case-control Study.
van Kalleveen, Michael W; Budding, Andries E; Benninga, Marc A; Savelkoul, Paul H M; van Gool, Tom; van Maldeghem, Iris; Dorigo-Zetsma, J W; Bart, Aldert; Plötz, Frans B; de Meij, Tim G J.
Afiliação
  • van Kalleveen MW; From the Department of Pediatrics, Tergooi Hospital, Blaricum, The Netherlands.
  • Budding AE; Department of Gastroenterology, Noordwest Hospital, Alkmaar, The Netherlands.
  • Benninga MA; Department of Medical Microbiology & Infection Control.
  • Savelkoul PHM; Department of Pediatric Gastroenterology, Emma Children's Hospital, Amsterdam UMC, Amsterdam, The Netherlands.
  • van Gool T; Department of Medical Microbiology & Infection Control.
  • van Maldeghem I; Department of Medical Microbiology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Dorigo-Zetsma JW; Department of Medical Microbiology, Section Clinical Parasitology, Amsterdam UMC, Amsterdam, The Netherlands.
  • Bart A; From the Department of Pediatrics, Tergooi Hospital, Blaricum, The Netherlands.
  • Plötz FB; Department of Medical Microbiology, Tergooi Hospital, Blaricum, The Netherlands.
  • de Meij TGJ; Department of Medical Microbiology, Tergooi Hospital, Blaricum, The Netherlands.
Pediatr Infect Dis J ; 40(4): 279-283, 2021 04 01.
Article em En | MEDLINE | ID: mdl-33181781
BACKGROUND: Dientamoeba fragilis in children has been associated with gastrointestinal symptoms, like abdominal pain and diarrhea. The mechanism underlying these symptoms in children with D. fragilis remains unclear. We hypothesized that concomitant microbial alterations, which have been described in other parasitic infections, may be associated with gastrointestinal symptoms in D. fragilis. METHODS: In this case-control study performed in 2 centers, 19 children referred to a pediatrician because of gastrointestinal symptoms and with a positive fecal PCR for D. fragilis were included as cases. We included 19 healthy children as controls and matched for age and gender, selected from an existing cohort of 63 children. A PCR for D. fragilis was performed on fecal samples of the 19 controls to assess D. fragilis carriership in this asymptomatic group. Microbiota was analyzed with the IS-pro technique, and the intestinal microbiota composition and diversity were compared between the 2 groups. RESULTS: Microbiota of children with D. fragilis and gastrointestinal symptoms did not significantly differ in terms of composition and diversity compared with controls, both on phylum and species level. In the asymptomatic controls, a positive fecal PCR for D. fragilis was found in 16 of 19 (84.2%). CONCLUSION: Intestinal microbiota does not seem to play a key role in the presence of clinical symptoms in children with D. fragilis. The pathogenicity of D. fragilis and pathophysiologic pathways underlying the development of gastrointestinal symptoms remains yet to be clarified.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Child / Child, preschool / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Child / Child, preschool / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article